Frontiers in Cardiovascular Medicine (Aug 2022)

Gender dimension in cardio-pulmonary continuum

  • Leah Hernandez,
  • Agne Laucyte-Cibulskiene,
  • Agne Laucyte-Cibulskiene,
  • Liam J. Ward,
  • Liam J. Ward,
  • Alexandra Kautzky-Willer,
  • Maria-Trinidad Herrero,
  • Colleen M. Norris,
  • Colleen M. Norris,
  • Valeria Raparelli,
  • Valeria Raparelli,
  • Valeria Raparelli,
  • Louise Pilote,
  • Peter Stenvinkel,
  • Karolina Kublickiene,
  • the GOING-FWD Consortium

DOI
https://doi.org/10.3389/fcvm.2022.916194
Journal volume & issue
Vol. 9

Abstract

Read online

Cardio-pulmonary diseases, which were once regarded as a man's illness, have been one of the leading causes of morbidity and mortality for both men and women in many countries in recent years. Both gender and sex influence the functional and structural changes in the human body and therefore play an important role in disease clinical manifestation, treatment choice, and/or response to treatment and prognosis of health outcomes. The gender dimension integrates sex and gender analysis in health sciences and medical research, however, it is still relatively overlooked suggesting the need for empowerment in the medical research community. Latest advances in the field of cardiovascular research have provided supportive evidence that the application of biological variables of sex has led to the understanding that heart disease in females may have different pathophysiology compared to males, particularly in younger adults. It has also resulted in new diagnostic techniques and a better understanding of symptomatology, while gender analysis has informed more appropriate risk stratification and prevention strategies. The existing knowledge in the pulmonary field shows the higher prevalence of pulmonary disorders among females, however, the role of gender as a socio-cultural construct has yet to be explored for the implementation of targeted interventions. The purpose of this review is to introduce the concept of gender dimension and its importance for the cardiopulmonary continuum with a focus on shared pathophysiology and disease presentation in addition to interrelation with chronic kidney disease. The review presents basic knowledge of what gender dimension means, and the application of sex and gender aspects in cardiovascular medicine with a specific focus on early pulmonary development, pulmonary hypertension, and chronic obstructive pulmonary disease (COPD). Early vascular aging and inflammation have been presented as a potential pathophysiological link, with further interactions between the cardiopulmonary continuum and chronic kidney disease. Finally, implications for potential future research have been provided to increase the impact of gender dimension on research excellence that would add value to everybody, foster toward precision medicine and ultimately improve human health.

Keywords